Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Presov

115 clinical trials in Presov, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Presov at a glance
115
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

115 trials in Presov

Open in trial search
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Presov

What the registry says about research in the country

01 Cardiovascular & Metabolic Research

Innovative clinical trials focusing on cardiovascular disease and metabolic conditions, investigating new treatments for heart conditions, stroke prevention, and diabetes management.

  • Atherosclerotic Disease Studies
  • Stroke Prevention Research
  • Type 2 Diabetes Management

Multiple studies evaluating novel therapies for reducing cardiovascular events and improving patient outcomes.

02 Inflammatory & Autoimmune Conditions

Comprehensive research into chronic inflammatory conditions, with particular focus on Crohn's Disease and ulcerative colitis treatments.

  • Gastrointestinal Disorders
  • Skin Conditions
  • Inflammatory Disease Management

Studies examining innovative biological therapies and their long-term effectiveness in treating autoimmune conditions.

03 Respiratory Medicine

Advanced research focusing on uncontrolled asthma and respiratory conditions, testing new therapeutic approaches for better disease control.

  • Asthma Management
  • Lung Function Studies
  • Respiratory Treatment Innovation

Clinical trials evaluating novel treatments to improve lung function and reduce asthma exacerbations.

04 Oncology Research

Groundbreaking studies in cancer treatment, particularly focusing on prostate cancer and breast cancer therapies.

  • Advanced Breast Cancer
  • Prostate Cancer Treatment
  • Targeted Cancer Therapies

Investigating innovative treatment combinations and targeted therapies for better cancer management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).